# Mangoceuticals, Inc.: Form SCHEDULE 13D/A, filed Oct 6, 2026

- Company: [Mangoceuticals, Inc.](/companies/mgrx.md) (CIK 1938046)
- Form: SCHEDULE 13D/A
- Filed: 2026-10-06
- Accepted by EDGAR: Oct 6, 2026, 08:00 ET
- Period: not reported
- Accession: 0001493152-26-045857
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1938046/000149315226045857/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1938046/000149315226045857/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1938046/000149315226045857/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Oct 6, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-045857. Last ingested by Listed: Nov 6, 2026, 18:28 ET. No prices; not investment advice.